PARIS | November 5th, 2024 – Bryan Garnier is pleased to present our insights from the recent EUROSPINE 2024 conference, held in Vienna, highlighting key trends and discussions that are shaping the future of spinal healthcare in Europe.
While the conference explored a broad range of advancements, it notably diverged from the tech-heavy, robotics-centered approach seen in U.S.-based conferences like NASS. Instead, Europe’s focus remains on surgical interventions for complex spine disorders, though a shift towards radiation-free navigation is beginning to take shape.
The conference underscored the ongoing debate around cost-effectiveness of navigation systems over robotics, sparking interest in VR alternatives as an affordable and practical solution. Additionally, a holistic approach was called for, advocating for improved diagnostics and planning across the surgical roadmap—a step towards more patient-centric care.
On the implant front, we observe significant momentum towards motion-enabling implants and innovations aimed at boosting fusion rates. Although implants may appear to be a more traditional sector, recent advancements continue to push boundaries, offering transformative potential in spinal health outcomes.
Our summary delves deeper into these insights, analysing the implications of these trends on the spine care industry and the evolution of the surgical landscape.
To explorer a full analysis of EUROSPINE 2024, download our report here.
Maria Vara
Equity Research Analyst | Healthcare
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.